Raymond James & Associates Ironwood Pharmaceuticals Inc Transaction History

Raymond James & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $266,492 - $306,768	-24,117 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$10.61 - $12.88 $25,654 - $31,143	2,418 Added 11.14%	24,117 $303,000
Q4 2021 Feb 08, 2022	BUY	$10.86 - $13.95 $235,651 - $302,701	21,699 New	21,699 $253,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.